| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 109777-05-1 | 1,1,2,2,3,3-Cyclopropanehexacarboxylicacid, 1,1,2,2,3,3-hexamethyl ester; Cyclopropanehexacarboxylicacid, hexamethyl ester (9CI); Hexacarbomethoxycyclopropane; Hexamethylcyclopropanehexacarboxylate |  | C15H18O12 | 詳情 | 供應商 | |
| 109775-43-1 | 1-Propen-2-ol,1-(4,5-dihydro-2-thiazolyl)-; 2-Thiazoline,2-(2-hydroxypropenyl)- (5CI) |  | C6H9NOS | 詳情 | 供應商 | |
| 109737-05-5 | 1H-Indole-5-aceticacid, 2,3-dihydro-2-oxo-, methyl ester; methyl 2-(2-oxoindolin-5-yl)acetate |  | C11H11NO3 | 詳情 | 供應商 | |
| 102000-79-3 | 1H-Pyrrolo[2,3-b]pyridin-5-amine,2,3-dihydro-; 1H-Pyrrolo[2,3-b]pyridine,5-amino-2,3-dihydro- (6CI) |  | C7H9N3 | 詳情 | 供應商 | |
| 1492-26-8 | 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-(1-oxobutoxy)-, inner salt; (3-Carboxy-2-hydroxypropyl)trimethylammoniumhydroxide, inner salt, butyrate (7CI); Ammonium,(3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, butyrate (8CI); Butyric acid, ester with (3-carboxy-2-hydroxypropyl)trimethylammoniumhydroxide, inner salt (8CI); (?à)-Butyrylcarnitine; Butyryl-DL-carnitine |  | C11H21NO4 | 詳情 | 供應商 | |
| 1484-39-5 | 1H-Benzimidazole,2-methyl-1-phenyl-; Benzimidazole,2-methyl-1-phenyl- (7CI,8CI); 1-Phenyl-2-methylbenzimidazole; 2-Methyl-1-phenylbenzimidazole |  | C14H12N2 | 詳情 | 供應商 | |
| 76777-03-2 | 1,6-Methano-2-benzazocine,1,2,3,4,5,6-hexahydro-2-propyl-, hydrochloride (1:1); 1,6-Methano-2-benzazocine,1,2,3,4,5,6-hexahydro-2-propyl-, hydrochloride (9CI) |  | C15H22ClN | 詳情 | 供應商 | |
| 7066-30-0 | 1H-Pyrrolo[3,4-b]quinoxaline-1,3(2H)-dione, 2-(phenylmethyl)-; 2,3-Quinoxalinedicarboximide,N-benzyl- (7CI,8CI) |  | C17H11N3O2 | 詳情 | 供應商 | |
| 371122-32-6 | 1H-Imidazole,4,5-dihydro-2-(3-thienylmethyl)-; 1H-Imidazole, 4,5-dihydro-2-(3-thienylmethyl)- |  | C8H10N2S | 詳情 | 供應商 | |
| 314065-37-7 | 1H-Imidazole,5-(3-octyn-1-yl)-; 1H-Imidazole,4-(3-octynyl)- (9CI) |  | C11H16N2 | 詳情 | 供應商 | |
| 32139-64-3 | 1,4-Methanonaphthalene-5,6-diol,7-ethyl-1,4-dihydro-; 1,4-Methanonaphthalene-5,6-diol, 7-ethyl-1,4-dihydro- (8CI) |  | C13H14O2 | 詳情 | 供應商 | |
| 34281-22-6 | 1,2-Ethane-1,1,2,2-d4-di(amine-d2)(9CI); Ethylenediamine-d8 |  | C2D8N2 | 詳情 | 供應商 | |
| 34277-32-2 | 1,3-Dioxaspiro[4.5]decan-2-one; 1,3-Dioxaspiro[4.5]decan-2-one |  | C8H12O3 | 詳情 | 供應商 | |
| 220655-14-1 | 1H-Pyrrole,3-hexadecyl-2,5-di-2-thienyl-; HDTP |  | C28H41NS2 | 詳情 | 供應商 | |
| 34273-12-6 | 1-9-Angiotensin I,5-L-isoleucine-; AngiotensinI, 5-L-isoleucine-10-de-L-leucine- (8CI); (Ile5,de-Leu10)-angiotensin I; 1-9-Angiotensin I (human); 11: PN: WO0239997 SEQID: 16 unclaimed sequence; 135:PN: WO02098448 SEQID: 145 unclaimed sequence; 135: PN: WO02098906 SEQID: 145unclaimed sequence; 16: PN: US6610497 SEQID: 16 unclaimed sequence; 16: PN:US6884771 SEQID: 16 unclaimed sequence; 16: PN: US6989363 SEQID: 16 unclaimedsequence; 8: PN: US20040209344 SEQID: 3 unclaimed sequence; 9: PN: WO0212471SEQID: 16 unclaimed sequence; Angiotensin-(1-9) (human) |  | C56H78N16O13 | 詳情 | 供應商 | |
| 102505-34-0 | 1,2-Diazabenzo[a]cyclopropa[cd]pentalene,2a,2b,6b,6c-tetrahydro- (9CI); 1,2-Diazabenzo[a]cyclopropa[cd]pentalene, 2a,2b,6b,6c-tetrahydro- (9CI) |  | C10H8N2 | 詳情 | 供應商 | |
| 102505-33-9 | 1,2-Diazabenzo[a]cyclopropa[cd]pentalene,1,2,2a,2b,6b,6c-hexahydro- (9CI); 1,2-Diazabenzo[a]cyclopropa[cd]pentalene, 1,2,2a,2b,6b,6c-hexahydro- (9CI) |  | C10H10N2 | 詳情 | 供應商 | |
| 102477-83-8 | 1-Propanone,3-[1,1'-biphenyl]-4-yl-1-phenyl-; Propiophenone,3-(4-biphenylyl)- (6CI) |  | C21H18O | 詳情 | 供應商 | |
| 19118-85-5 | 1,3,2-Dioxaborinane,2-hydroxy-; 1,3-Propanediol,cyclic ester with boric acid (H3BO3) (8CI) |  | C3H7BO3 | 詳情 | 供應商 | |
| 19107-42-7 | 1-Piperidinamine,4-methyl-; 4-Pipecoline,1-amino- (7CI,8CI); 1-Amino-4-methyl-2-piperidine; 1-Amino-4-methylpiperidine; N-Amino-4-methylpiperidine |  | C6H14N2 | 詳情 | 供應商 | |